Table 2 HD chemotherapy and transplant characteristics
Parameters | Overall cohort |
|---|---|
ABSCT number, n | 21 |
Age at ABSCT, years | 59 (51–70) |
Therapy line, n (%) | |
First line therapy | 15 (71) |
Salvage therapy | 6 (29) |
Remission prior HD/ABSCT, (%) | |
CR | 0 (0) |
nCR | 5 (24) |
VGPR | 6 (29) |
PR | 8 (38) |
MR | 0 (0) |
SD | 1 (5) |
PD | 1 (5) |
HD chemotherapy | |
HD melphalan n, (%) | 20 (95) |
Dose modification, n (%) | 1 (5) |
ABSCT | |
Transplanted CD34+ cells × 106/kg | 3.3 (2.1–6.5) |
PBSC storage duration, months | 2 (0–144) |
Remission post HD and ABSCT | |
CR | 2 (10) |
nCR | 8 (38) |
VGPR | 3 (14) |
PR | 7 (33) |
MR | 0 (0) |
SD | 1 (5) |
PD | 0 (0) |